Last reviewed · How we verify

NCT03895138

Trial to Investigate the in Silico Optimization of Insulin Treatments

Status unknown NA Last updated 29 March 2019
What this trial tests

NA trial testing Standard Glucommander Protocol (SGP) in Coronary Artery Bypass in 35 participants. Status unknown.

Timeline
19 March 2018
Primary endpoint
30 April 2019
30 April 2019

Quick facts

Lead sponsorUniversity of Virginia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment35
Start date19 March 2018
Primary completion30 April 2019
Estimated completion30 April 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Virginia

Who can join

Adults 40 to 75, any sex, with Coronary Artery Bypass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to assess the performance of an in silico designed alternative protocol for control of stress hyperglycemia of inpatients treated for Coronary Artery Bypass Graft (CABG) or valve replacement surgery in the University of Virginia cardiothoracic ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Bypass

Currently open trials in the same condition.

Other University of Virginia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing